Optimizing Biologic Therapy for the Prevention of Post-Operative Recurrence in Crohn’s Disease: Current Evidence and Future Perspectives
Crohn’s disease (CD) imposes a substantial burden on patients due to its chronic, relapsing nature, often necessitating surgical intervention. However, surgery is not curative, and post-operative recurrence (POR) remains a major clinical challenge, with up to 80% of patients developing endoscopic re...
Saved in:
| Main Authors: | Reem Aljabri, Saqer Al-Saraie, Ahmed Alhouti |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-05-01
|
| Series: | Biomedicines |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2227-9059/13/5/1232 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Efficacy of IL-23 inhibitors and IL-12/23 inhibitors in the induction treatment of Crohn’s disease: A meta-analysis based on randomized controlled trials
by: Boyang Gao, et al.
Published: (2024-01-01) -
JAK Inhibitor and Crohn’s Disease
by: Mengyan Xu, et al.
Published: (2025-05-01) -
State-of-the-Art Review on the Treatment of Axial Spondyloarthritis
by: Evripidis Kaltsonoudis, et al.
Published: (2025-03-01) -
IgA Vasculitis Induced by Ustekinumab During Treatment for Crohn’s Disease: A Case Report
by: Yu Okada, et al.
Published: (2025-08-01) -
Mirikizumab: A promising breakthrough in Crohn's disease treatment
by: Muaaz Aslam, et al.
Published: (2024-08-01)